The global medical imaging workstations market size accounted for USD 9.40 billion in 2024, grew to USD 9.96 billion in 2025 and is expected to be worth around USD 16.73 billion by 2034, registering a CAGR of 5.94% between 2024 and 2034. The North America medical imaging workstations market size is calculated at USD 3.48 billion in 2024 and is expected to grow at a CAGR of 6.07% during the forecast year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Medical Imaging Workstations Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Medical Imaging Workstations Market, by Usage Mode, 2024-2034
8.1.1. Thick Client Workstations
8.1.1.1. Market Revenue and Forecast (2021-2034)
8.1.2. Thin Client Workstations
8.1.2.1. Market Revenue and Forecast (2021-2034)
9.1. Medical Imaging Workstations Market, by Application, 2024-2034
9.1.1. Conventional Imaging
9.1.1.1. Market Revenue and Forecast (2021-2034)
9.1.2. Advanced Imaging
9.1.2.1. Market Revenue and Forecast (2021-2034)
10.1. Medical Imaging Workstations Market, by Component, 2024-2034
10.1.1. Visualization Software
10.1.1.1. Market Revenue and Forecast (2021-2034)
10.1.2. Hardware
10.1.2.1. Market Revenue and Forecast (2021-2034)
11.1. Medical Imaging Workstations Market, by Modality, 2024-2034
11.1.1. Computed Tomography (CT)
11.1.1.1. Market Revenue and Forecast (2021-2034)
11.1.2. Magnetic Resonance Imaging (MRI)
11.1.2.1. Market Revenue and Forecast (2021-2034)
11.1.3. Ultrasound
11.1.3.1. Market Revenue and Forecast (2021-2034)
11.1.4. Mammography
11.1.4.1. Market Revenue and Forecast (2021-2034)
12.1. North America
12.1.1. Market Revenue and Forecast, by Usage Mode (2021-2034)
12.1.2. Market Revenue and Forecast, by Application (2021-2034)
12.1.3. Market Revenue and Forecast, by Component (2021-2034)
12.1.4. Market Revenue and Forecast, by Modality (2021-2034)
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Usage Mode (2021-2034)
12.1.5.2. Market Revenue and Forecast, by Application (2021-2034)
12.1.5.3. Market Revenue and Forecast, by Component (2021-2034)
12.1.5.4. Market Revenue and Forecast, by Modality (2021-2034)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Usage Mode (2021-2034)
12.1.6.2. Market Revenue and Forecast, by Application (2021-2034)
12.1.6.3. Market Revenue and Forecast, by Component (2021-2034)
12.1.6.4. Market Revenue and Forecast, by Modality (2021-2034)
12.2. Europe
12.2.1. Market Revenue and Forecast, by Usage Mode (2021-2034)
12.2.2. Market Revenue and Forecast, by Application (2021-2034)
12.2.3. Market Revenue and Forecast, by Component (2021-2034)
12.2.4. Market Revenue and Forecast, by Modality (2021-2034)
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Usage Mode (2021-2034)
12.2.5.2. Market Revenue and Forecast, by Application (2021-2034)
12.2.5.3. Market Revenue and Forecast, by Component (2021-2034)
12.2.5.4. Market Revenue and Forecast, by Modality (2021-2034)
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Usage Mode (2021-2034)
12.2.6.2. Market Revenue and Forecast, by Application (2021-2034)
12.2.6.3. Market Revenue and Forecast, by Component (2021-2034)
12.2.6.4. Market Revenue and Forecast, by Modality (2021-2034)
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Usage Mode (2021-2034)
12.2.7.2. Market Revenue and Forecast, by Application (2021-2034)
12.2.7.3. Market Revenue and Forecast, by Component (2021-2034)
12.2.7.4. Market Revenue and Forecast, by Modality (2021-2034)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Usage Mode (2021-2034)
12.2.8.2. Market Revenue and Forecast, by Application (2021-2034)
12.2.8.3. Market Revenue and Forecast, by Component (2021-2034)
12.2.8.4. Market Revenue and Forecast, by Modality (2021-2034)
12.3. APAC
12.3.1. Market Revenue and Forecast, by Usage Mode (2021-2034)
12.3.2. Market Revenue and Forecast, by Application (2021-2034)
12.3.3. Market Revenue and Forecast, by Component (2021-2034)
12.3.4. Market Revenue and Forecast, by Modality (2021-2034)
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Usage Mode (2021-2034)
12.3.5.2. Market Revenue and Forecast, by Application (2021-2034)
12.3.5.3. Market Revenue and Forecast, by Component (2021-2034)
12.3.5.4. Market Revenue and Forecast, by Modality (2021-2034)
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Usage Mode (2021-2034)
12.3.6.2. Market Revenue and Forecast, by Application (2021-2034)
12.3.6.3. Market Revenue and Forecast, by Component (2021-2034)
12.3.6.4. Market Revenue and Forecast, by Modality (2021-2034)
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Usage Mode (2021-2034)
12.3.7.2. Market Revenue and Forecast, by Application (2021-2034)
12.3.7.3. Market Revenue and Forecast, by Component (2021-2034)
12.3.7.4. Market Revenue and Forecast, by Modality (2021-2034)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Usage Mode (2021-2034)
12.3.8.2. Market Revenue and Forecast, by Application (2021-2034)
12.3.8.3. Market Revenue and Forecast, by Component (2021-2034)
12.3.8.4. Market Revenue and Forecast, by Modality (2021-2034)
12.4. MEA
12.4.1. Market Revenue and Forecast, by Usage Mode (2021-2034)
12.4.2. Market Revenue and Forecast, by Application (2021-2034)
12.4.3. Market Revenue and Forecast, by Component (2021-2034)
12.4.4. Market Revenue and Forecast, by Modality (2021-2034)
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Usage Mode (2021-2034)
12.4.5.2. Market Revenue and Forecast, by Application (2021-2034)
12.4.5.3. Market Revenue and Forecast, by Component (2021-2034)
12.4.5.4. Market Revenue and Forecast, by Modality (2021-2034)
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Usage Mode (2021-2034)
12.4.6.2. Market Revenue and Forecast, by Application (2021-2034)
12.4.6.3. Market Revenue and Forecast, by Component (2021-2034)
12.4.6.4. Market Revenue and Forecast, by Modality (2021-2034)
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Usage Mode (2021-2034)
12.4.7.2. Market Revenue and Forecast, by Application (2021-2034)
12.4.7.3. Market Revenue and Forecast, by Component (2021-2034)
12.4.7.4. Market Revenue and Forecast, by Modality (2021-2034)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Usage Mode (2021-2034)
12.4.8.2. Market Revenue and Forecast, by Application (2021-2034)
12.4.8.3. Market Revenue and Forecast, by Component (2021-2034)
12.4.8.4. Market Revenue and Forecast, by Modality (2021-2034)
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Usage Mode (2021-2034)
12.5.2. Market Revenue and Forecast, by Application (2021-2034)
12.5.3. Market Revenue and Forecast, by Component (2021-2034)
12.5.4. Market Revenue and Forecast, by Modality (2021-2034)
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Usage Mode (2021-2034)
12.5.5.2. Market Revenue and Forecast, by Application (2021-2034)
12.5.5.3. Market Revenue and Forecast, by Component (2021-2034)
12.5.5.4. Market Revenue and Forecast, by Modality (2021-2034)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Usage Mode (2021-2034)
12.5.6.2. Market Revenue and Forecast, by Application (2021-2034)
12.5.6.3. Market Revenue and Forecast, by Component (2021-2034)
12.5.6.4. Market Revenue and Forecast, by Modality (2021-2034)
13.1. Accuray Incorporated
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. CANON MEDICAL SYSTEMS CORPORATION
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Carestream Health
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. CARL ZEISS MEDITEC AG
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. FUJIFILM Holdings Corporation
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. GE HealthCare
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Koninklijke Philips N.V.
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. NGI Group
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. Siemens Healthineers AG
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
15.1. About Us
15.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample